Get notified when MCRB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsSeres Therapeutics reports Q1 2026 financial results and operational updates
Filed May 5, 2026 · Period ending May 5, 2026 · ~1 min read
Key Changes
-
high
Company announced financial results for the quarter ended March 31, 2026, along with operational updates via press release. Specific figures and details are contained in the attached exhibit.
Item 2.02 verify on EDGAR → -
low
Press release issued May 5, 2026 and furnished as Exhibit 99.1 to the 8-K filing. The filing body itself contains no financial figures or operational details.
Item 9.01 verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade MCRB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify